Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.470
-0.140 (-3.88%)
Mar 25, 2025, 4:00 PM EDT - Market open

Eledon Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
18.6112.6913.113.437.35
Upgrade
Research & Development
51.9630.3126.6823.445.93
Upgrade
Operating Expenses
70.584339.7836.8713.28
Upgrade
Operating Income
-70.58-43-39.78-36.87-13.28
Upgrade
Other Non Operating Income (Expenses)
34.82-73.540.460.010.08
Upgrade
EBT Excluding Unusual Items
-35.75-116.54-39.32-36.86-13.2
Upgrade
Merger & Restructuring Charges
-----5.18
Upgrade
Impairment of Goodwill
---48.65--
Upgrade
Other Unusual Items
-----4.83
Upgrade
Pretax Income
-35.75-116.54-87.97-36.86-23.22
Upgrade
Income Tax Expense
0.43---2.35-0.4
Upgrade
Net Income
-36.18-116.54-87.97-34.51-22.81
Upgrade
Net Income to Common
-36.18-116.54-87.97-34.51-22.81
Upgrade
Shares Outstanding (Basic)
492514151
Upgrade
Shares Outstanding (Diluted)
492514151
Upgrade
Shares Change (YoY)
97.18%72.34%-3.61%921.03%121.42%
Upgrade
EPS (Basic)
-0.75-4.73-6.16-2.33-15.72
Upgrade
EPS (Diluted)
-0.75-4.73-6.16-2.33-15.72
Upgrade
Free Cash Flow
-47.27-39.53-28.42-28.91-15.21
Upgrade
Free Cash Flow Per Share
-0.97-1.61-1.99-1.95-10.48
Upgrade
EBITDA
----36.86-13.28
Upgrade
D&A For EBITDA
---0.010.01
Upgrade
EBIT
-70.58-43-39.78-36.87-13.28
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q